Literature DB >> 8512107

Delayed onset of malignant hyperthermia induced by isoflurane and desflurane compared with halothane in susceptible swine.

D J Wedel1, S A Gammel, J H Milde, P A Iaizzo.   

Abstract

BACKGROUND: Desflurane (difluoromethyl 1-fluoro 2,2,2-trifluoroethyl ether) is a new inhalational anesthetic currently under investigation for use in humans. Recently, the authors showed that desflurane is a trigger of malignant hyperthermia (MH) in susceptible swine. To date, there has been no in vivo comparison of the relative ability of inhalational anesthetics to trigger MH. The effects of desflurane, isoflurane, and halothane on six MH-susceptible purebred and six MH-susceptible mixed-bred Pietrain swine were examined.
METHODS: The animals were exposed to 1 MAC and 2 MAC (if MH was not triggered after 1 MAC hour) doses of each of the three volatile anesthetics in random sequence at 7-10-day intervals and changes in end-tidal CO2, arterial blood gases, serum lactate, core and muscle temperature, blood pressure, and heart rate were measured.
RESULTS: There was a statistical difference between anesthetics in the time required to trigger MH; halothane exposure resulted in the fastest onset of an MH episode (20 +/- 5 min), compared with isoflurane (48 +/- 24 min) and desflurane (65 +/- 28 min), both of which required significantly longer exposures. There was no statistical difference between the MH purebred and mixed-bred swine in the time required to trigger MH (defined as a PaCO2 of 70 mmHg) with a given agent, and time to triggering was also independent of the order of exposure to the three anesthetics. Malignant hyperthermia susceptibility was confirmed in ten surviving animals, by both in vivo succinylcholine challenge and in vitro contracture testing.
CONCLUSIONS: Although all three volatile anesthetics triggered MH, exposure to halothane resulted in significantly shorter times to MH triggering when compared with desflurane and isoflurane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512107     DOI: 10.1097/00000542-199306000-00018

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  12 in total

Review 1.  [Malignant hyperthermia].

Authors:  T Metterlein; F Schuster; B M Graf; M Anetseder
Journal:  Anaesthesist       Date:  2014-12       Impact factor: 1.041

2.  Malignant hyperthermia involving the administration of desflurane.

Authors:  E S Fu; J E Scharf; D Mangar; W D Miller
Journal:  Can J Anaesth       Date:  1996-07       Impact factor: 5.063

Review 3.  Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 4.  Desflurane clinical pharmacokinetics and pharmacodynamics.

Authors:  J E Caldwell
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

5.  A defect in dystrophin causes a novel porcine stress syndrome.

Authors:  Dan J Nonneman; Tami Brown-Brandl; Shuna A Jones; Ralph T Wiedmann; Gary A Rohrer
Journal:  BMC Genomics       Date:  2012-06-12       Impact factor: 3.969

6.  Desflurane - revisited.

Authors:  Mukul Chandra Kapoor; Mahesh Vakamudi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-01

Review 7.  In vitro contractile studies within isolated tissue baths: Translational research from Visible Heart® Laboratories.

Authors:  Weston J Upchurch; Paul A Iaizzo
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-22

8.  Evaluation of suspected malignant hyperthermia events during anesthesia.

Authors:  Frank Schuster; Stephan Johannsen; Daniel Schneiderbanger; Norbert Roewer
Journal:  BMC Anesthesiol       Date:  2013-09-23       Impact factor: 2.217

9.  Malignant hyperthermia during laparoscopic adjustable gastric banding.

Authors:  Josue Chery; Chiba Shintaro; Ambibola Pratt; Ronell Kirkley; Barbara Hearne; Andrew Beyzman; Piotr Gorecki
Journal:  JSLS       Date:  2013 Apr-Jun       Impact factor: 2.172

10.  Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.

Authors:  Werner Klingler; Sebastian Heiderich; Thierry Girard; Elvira Gravino; James Ja Heffron; Stephan Johannsen; Karin Jurkat-Rott; Henrik Rüffert; Frank Schuster; Marc Snoeck; Vincenzo Sorrentino; Vincenzo Tegazzin; Frank Lehmann-Horn
Journal:  Orphanet J Rare Dis       Date:  2014-01-16       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.